Exagen
In Brief This Week:, Thermo Fisher Scientific, Agilent, Labcorp, More
News items for the week of Jan. 9, 2023.
Earnings Roundup: Accelerate Diagnostics, Exagen, Lucira Health, More
Accelerate, Exagen, Lucira, Lucid Diagnostics, and Interpace Biosciences reported their quarterly financial results this week.
Earnings Roundup: Chembio Diagnostics, Exagen, Opko Health, Biodesix
Chembio, Exagen, and other firms reported quarterly financials this week.
Exagen Q1 Revenues Drop 2 Percent
Testing revenues grew slightly during the quarter, driven by an increase in Avise test orders.
Exagen, QMUL to Develop Molecular Signatures for Rheumatoid Arthritis Therapy Selection
The assays under development will segment patients according to gene expression in their synovial tissue biopsies to personalize therapy selection.
Nov 10, 2021
Exagen Q3 Revenues Rise 14 Percent
Oct 25, 2021
Exagen Enters $27.2M Debt Refinancing Agreement
Aug 9, 2021
Exagen Posts 43 Percent Increase in Q2 Revenues
May 11, 2021
Exagen Q1 Revenues Grow 10 Percent
Mar 23, 2021
Exagen Prices $60.1M Public Offering of Stock
May 11, 2020
Exagen Q1 Revenues Grow 3 Percent
Nov 25, 2019